NCT01366560View on ClinicalTrials.gov

Effect of GSK962040 on Oesophageal Function

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

October 22, 2010

Study Completion Date

October 22, 2010

Conditions

Gastrointestinal Motility

Interventions

DRUG

Active

GSK962040 125mg

DRUG

Placebo

Matching Placebo

Trial Locations (1)

CB2 2GG

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01366560 - Effect of GSK962040 on Oesophageal Function | Biotech Hunter | Biotech Hunter